Trading Statement

Craneware plc 11 January 2008 Craneware plc ('Craneware' or the 'Company') H1 TRADING UPDATE 11 January 2008 - Craneware plc, (AIM: CRW) a leader in revenue cycle management software solutions for the US healthcare market, is pleased to give an update today on trading during the half year to 31 December 2007. Following the Company's IPO on AIM in September 2007, Craneware has executed on its strategy to further advance its market leading position. In the six months to 31 December 2007, the Company signed up 96 new hospitals, compared to 64 in the previous corresponding period. As a result, the Company's software is now being used in 878 hospitals in the US, up from 800 at the beginning of the year. Revenue for the first half of the year was in line with management expectations, with new sales bookings being over 50% higher than the previous corresponding period. Craneware's flagship product, Chargemaster Toolkit(R), was also once again named top in its class by the prestigious industry research house KLAS in the US. As stated at the time of the IPO, the Company believes there is a significant opportunity to sell additional software products into its customer base and as such has added two further products to its suite aimed at the finance department of US hospitals. In November, Craneware launched Patient Charge Estimator(TM), which enables hospitals to efficiently and accurately provide prospective patients with estimates of procedural charges. Yesterday the Company launched Pharmacy ChargeLink(TM) which enables hospitals to improve the buying, billing and reimbursement of pharmacy items. Craneware has started the second half of the year with a strong pipeline of sales prospects and this together with the new product launches gives management confidence for the Company's performance for the full year. Overall, significant progress has been made in H1 and the Company anticipates further positive newsflow in H2. Craneware will be announcing Interim results on Tuesday 26th February 2008. Keith Neilson, CEO of Craneware, commented, 'We are delighted with the progress made during the first few months of life as a public company. Craneware continues to grow and we have maintained our leading position as a provider of revenue cycle management software to US hospitals. The complexity of legislation governing this sector, and the high proportion of hospitals still using manual solutions to manage their revenue cycles, means we are operating in a vibrant marketplace with opportunity for growth alongside continuing high levels of contract renewals. We look forward to updating shareholders in February.' For further information, please contact: Craneware plc KBC Peel Hunt ICIS +44 (0)1506 407 666 +44 (0)20 7418 8900 +44 (0)20 7651 8688 Keith Neilson, CEO Oliver Scott Tom Moriarty Sandy McDougall, CFO Deon Veldtman Caroline Evans-Jones About Craneware Founded in 1999, Craneware has headquarters in Livingston, Scotland, with offices in Florida, Arizona and Kansas, employing approximately 100 staff. The Company's flagship product, Chargemaster Toolkit(R) ('CMT'), assists US healthcare providers in reducing billing errors, ensuring the timely and accurate submission of claims and managing compliance risk. More information about Craneware plc and its services can be found on-line at the Company's corporate website, www.craneware.com This information is provided by RNS The company news service from the London Stock Exchange

Companies

Craneware (CRW)
UK 100

Latest directors dealings